China SXT Pharmaceuticals, Inc. Ratios

Ratios Mar2017 Mar2018 Mar2019 Mar2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Profitability
Gross Margin 47.36%48.46%65.77%52.37%59.43%48.10%21.62%28.73%21.11%
EBT Margin 32.37%23.19%25.55%-201.26%-61.56%-207.82%-301.00%-160.67%-189.77%
EBIT Margin 32.82%23.25%25.24%-30.19%-45.99%-199.43%-284.40%-130.42%-153.97%
EBITDA Margin 22.74%20.42%19.00%-211.71%-34.11%-203.96%-359.52%-203.62%-192.62%
Operating Margin 32.82%23.25%25.24%-30.19%-45.99%-199.43%-284.40%-130.42%-153.97%
Net Margin 24.28%16.92%21.95%-199.29%-57.52%-220.43%-301.00%-160.67%-189.77%
FCF Margin 2.33%18.90%-4.23%12.75%-27.87%10.25%-4.10%-99.98%-134.72%
Efficiency
Inventory Average 1.14M0.95M0.88M0.94M0.77M0.66M0.81M
Assets Average 19.59M28.12M34.05M31.55M26.34M22.40M
Equity Average 2.57M7.20M10.25M12.68M16.19M15.56M14.31M14.69M
Invested Capital 1.85M3.29M11.15M9.44M28.11M17.55M14.79M14.05M15.54M
Asset Utilization Ratio 0.260.170.080.060.070.08
Leverage & Solvency
Interest Coverage Ratio 39.670.00M342.00-0.47-1.36-141.43-11.76-4.62-4.14
Debt to Equity 0.230.710.760.000.020.040.05
Debt Ratio 0.140.310.350.000.010.030.04
Equity Ratio 0.640.430.460.490.500.600.71
Times Interest Earned 39.670.00M342.00-0.47-1.36-141.43-11.76-4.62-4.14
Valuation
Enterprise Value -0.07M-0.76M143.97M5.43M15.16M-10.89M-15.04M-9.70M-8.38M
Market Capitalization 153.42M12.72M28.55M4.72M2.33M2.37M9.75M
Return Ratios
Return on Sales 0.24%0.17%0.22%-1.99%-0.58%-2.20%-3.01%-1.61%-1.90%
Return on Capital Employed -0.21%-0.23%-0.31%-0.33%-0.14%-0.16%
Return on Invested Capital 0.46%0.21%-0.15%-0.11%
Return on Assets -0.53%-0.10%-0.17%-0.19%-0.12%-0.15%
Return on Equity 0.46%0.21%-1.00%-0.22%-0.35%-0.38%-0.22%-0.22%